Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Feasibility and Implementation of the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections

Blood (2024) 144 (Supplement 1): 2393.

https://doi.org/10.1182/blood-2024-203892

Published: 2024

Journal Articles

Outcomes of Therapy of Monoclonal Gammopathy of Renal Significance (MGRS)

Divaya Bhutani, Rajshekhar Chakraborty, Suzanne Lentzsch, J Christine Ye, Samuel M. Rubinstein, Sascha Tuchman, Eben I Lichtman

Blood (2024) 144 (Supplement 1): 6895.

https://doi.org/10.1182/blood-2024-210587

Published: 2024

Journal Articles

Population-Level Outcomes in Solitary Plasmacytoma: A Surveillance, Epidemiology, and End Results (SEER) Study

Daniel K Reef, Jorge A Florindez, Sascha Tuchman, Eben I Lichtman, Samuel M. Rubinstein

Blood (2024) 144 (Supplement 1): 1958.

https://doi.org/10.1182/blood-2024-211849

Published: 2024

Journal Articles

Initial Results from the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections

Blood (2024) 144 (Supplement 1): 1972.

https://doi.org/10.1182/blood-2024-210377

Published: 2024

Journal Articles

Spotlight: Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

Sharmilee Nuli, Rajshekhar Chakraborty, Al-Ola Abdallah, Suzanne Lentzsch, Evguenia Ouchveridze, Douglas W Sborov, Amandeep Godara, Brian McClune, Ah-Reum Jeong, Samuel M. Rubinstein, Aaron Goodman, Ghulam Rehman Mohyuddin

Blood (2024) 144 (Supplement 1): 6924.

https://doi.org/10.1182/blood-2024-203731

Published: 2024

Journal Articles

Evaluating the Accuracy of Artificial Intelligence(AI)-Generated Synopses for Plasma Cell Disorder Treatment Regimens

Aleenah Mohsin, Samuel M. Rubinstein, Rahul Banerjee, Sanjay Mishra, Mary Kwok, Peter Yang, Jeremy Lyle Warner, Andrew J. Cowan

Blood (2024) 144 (Supplement 1): 7513.

https://doi.org/10.1182/blood-2024-208513

Published: 2024

Journal Articles

Development of the ASH Research Collaborative Multiple Myeloma Program: A Multicenter, Real-World Evidence Generation Network

Blood (2024) 144 (Supplement 1): 3792.5.

https://doi.org/10.1182/blood-2024-210957

Published: 2024

Journal Articles

Association of p16, a Biomarker of Cellular Senescence, with Receipt of Therapy for Plasma Cell Disorders

Christopher Edward Jensen, Shweta Srikanth, Allison M Deal, Sascha Alexander Tuchman, Natalia Mitin, Nicholas Mangieri, Samuel M Rubinstein, Kirsten A Nyrop, Hyman B Muss, Eben I Lichtman

Blood (2023) 142 (Supplement 1): 6619.

https://doi.org/10.1182/blood-2023-172437

Published: 2023

Journal Articles

Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Daniel T Peters, Jacob Amburn, Sascha Tuchman, Eben I Lichtman, Christopher Edward Jensen, Koyal Jain, Suzanne Lentzsch, Rajshekhar Chakraborty, Divaya Bhutani, Samuel M Rubinstein

Blood (2023) 142 (Supplement 1): 2027.

https://doi.org/10.1182/blood-2023-189341

Published: 2023

Journal Articles

Performance of Newer Staging Systems for Myeloma in a Contemporary, Large Cohort of Patients in the United States

Ghulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji Kunnathu Kumar, S. Vincent Rajkumar, Rafael Fonseca, Nadine Abdallah, Greg Calip, Xiaoyan Wang, Christina Parrinello, Doug Sborov

Blood (2023) 142 (Supplement 1): 1068.

https://doi.org/10.1182/blood-2023-185136

Published: 2023

Journal Articles

A Cross-Sectional Analysis of County-Level Social Vulnerability and Physical Frailty Among Adults with Hematological Malignancies

Shakira J. Grant, Allison M. Deal, Hillary M. Heiling, Kirsten A Nyrop, Hyman B Muss, Samuel M. Rubinstein, Eben I Lichtman, Tanya M. Wildes, Sascha A. Tuchman

Blood (2021) 138 (Supplement 1): 4130.

https://doi.org/10.1182/blood-2021-149742

Published: 2021

Journal Articles

Thrombosis in the modern era of multiple myeloma

Samuel M. Rubinstein, Sascha A. Tuchman

Blood (2020) 136 (9): 1019–1021.

https://doi.org/10.1182/blood.2020006648

Published: 2020

Journal Articles

Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on Outcomes

Tarsheen Sethi, MD MBBS, Alexandra E. Kovach, MD, Samuel M Rubinstein, MD, Laura Lee, MDPhD, Yang Wang, PhD, David S. Morgan, MD, John P Greer, MD, Cindy Vnencak-Jones, PhD, Nishitha Reddy, MD MSCI, MBBS

Blood (2016) 128 (22): 929.

https://doi.org/10.1182/blood.V128.22.929.929

Published: 2016

Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD

Blood (2016) 128 (22): 3438.

https://doi.org/10.1182/blood.V128.22.3438.3438

Published: 2016

Journal Articles

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

Ilka Decker, MD MS, Oluchi C. Ukaegbu, MD, Stacey A. Goodman, MD MS, Daniel J. Lenihan, MD, Rebecca R Hung, MD, Adetola A. Kassim, MD MS, Shelton L. Harrell, MSN, ACNP-BC, Kevin McDonagh, MD, Sharon E. Phillips, MSPH, Kyle T Rawling, Samuel M Rubinstein, MD, Tarsheen K. Sethi, MD MS, Robert F Cornell, MD MS

Blood (2015) 126 (23): 1841.

https://doi.org/10.1182/blood.V126.23.1841.1841

Published: 2015

Journal Articles

The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6

Y Shabo, J Lotem, M Rubinstein, M Revel, SC Clark, SF Wolf, R Kamen, L Sachs

Blood (1988) 72 (6): 2070–2073.

https://doi.org/10.1182/blood.V72.6.2070.2070

Published: 1988

Journal Articles

Studies on Abnormal Hemoglobins : x. A New Syndrome: Hemoglobin C—Thalassemia Disease

KARL SINGER, ALFRED P. KRAUS, LILY SINGER, HERBERT M. RUBINSTEIN, SEYMOUR R. GOLDBERG

Blood (1954) 9 (11): 1032–1046.

https://doi.org/10.1182/blood.V9.11.1032.1032

Published: 1954

Journal Articles

Studies on Abnormal Hemoglobins : IX. Pure (Homozygous) Hemoglobin C Disease

KARL SINGER, A. ZERNE CHAPMAN, SEYMOUR R. GOLDBERG, HERBERT M. RUBINSTEIN, SOL A. ROSENBLUM

Blood (1954) 9 (11): 1023–1031.

https://doi.org/10.1182/blood.V9.11.1023.1023

Published: 1954

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Feasibility and Implementation of the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections

Outcomes of Therapy of Monoclonal Gammopathy of Renal Significance (MGRS)

Population-Level Outcomes in Solitary Plasmacytoma: A Surveillance, Epidemiology, and End Results (SEER) Study

Initial Results from the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections

Spotlight: Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

Evaluating the Accuracy of Artificial Intelligence(AI)-Generated Synopses for Plasma Cell Disorder Treatment Regimens

Development of the ASH Research Collaborative Multiple Myeloma Program: A Multicenter, Real-World Evidence Generation Network

Association of p16, a Biomarker of Cellular Senescence, with Receipt of Therapy for Plasma Cell Disorders

Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Performance of Newer Staging Systems for Myeloma in a Contemporary, Large Cohort of Patients in the United States

A Cross-Sectional Analysis of County-Level Social Vulnerability and Physical Frailty Among Adults with Hematological Malignancies

Thrombosis in the modern era of multiple myeloma

Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on Outcomes

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6

Studies on Abnormal Hemoglobins : x. A New Syndrome: Hemoglobin C—Thalassemia Disease

Studies on Abnormal Hemoglobins : IX. Pure (Homozygous) Hemoglobin C Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only